Trial
NCT01295073
Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of British Columbia
Collaborators
—
Condition
Macular Edema Following Cataract Surgery
Intervention
Trientine Hydrochloride
Why stopped
appropriate study medication supply could not be identified
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-09